News Headlines Article

Breast Cancer Gene Test Helps Predict Who Can Skip Chemo
National Public Radio

For the past 10 years, doctors have used a genetic test to decide which patients may be able to skip chemotherapy after surgery for breast cancer.

Now a study confirms that this test, called Oncotype DX, works well for a small group of patients. But a longer, follow-up study is needed to draw conclusions for a fuller range of patients with riskier tumors.

Oncotype DX analyzes 21 genes in the tumor to estimate a woman’s risk of the cancer coming back after surgery.

Commands